“Tirzepatide Protects the Heart from Doxorubicin-induced Cardiotoxicity via Modulating ER Stress”, Multidisciplinary, Scientific Work and Management Journal, vol. 36, no. 1, pp. 3056–3061, Mar. 2026, doi: 10.7492/ma41ae60.